2020-02-13 // Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19

Go to Article

2020-01-14 // Gates vets at Adjuvant back Codagenix’s software-driven approach to recoding RSV, fly oncolytic viruses and more

Go to Article

2020-01-13 // Codagenix raises $20 million for a new flu vaccine and other therapies

Go to Article

2019-11-21 // AN2 Therapeutics Raises $12M in Series A Funding

Go to Article

2019-11-21 // AN2 Therapeutics Launches with $12 Million in Series A Funding and Announces a Strategic Partnership with Brii Biosciences

Go to Article

2019-09-23 // Financing Global Health

Go to Article